PerformRx

performrx.com

Formed in 1999, PerformRx, LLC is a URAC accredited pharmacy benefits manager servicing lines of business including Medicaid, Medicare, and Commercial markets. A large percentage of the staff at PerformRx are pharmacists and pharmacy technicians. This ensures that the company maintains a culture of clinical influence and care throughout each business area. Clients receive a personalized solution designed to understand their benefit and meet their needs. This includes offering clients standalone products and services as well as full pharmacy benefit management. PerformRx ensures these solutions by utilizing technology that adapts to specific member populations and changes in the health care landscape.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

news image

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

news image

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More

Business Insights

AVIDIEN TECHNOLOGIES RECEIVES $4M INVESTMENT FROM BROADOAK CAPITAL PARTNERS

Avidien Technologies | February 02, 2022

news image

Avidien announced a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. "The partnership with BroadOak is exciting and ushers in the next phase for Avidien by creating the opportunity to quickly scale up the business with investments in new products, sales, marketing, and manufacturing." ...

Read More

Pharma Tech

INVITAE TO ACQUIRE CIITIZEN TO STRENGTHEN ITS PATIENT-CONSENTED HEALTH DATA PLATFORM TO IMPROVE PERSONAL OUTCOMES AND GLOBAL RESEARCH

Invitae | September 07, 2021

news image

Invitae , a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z, Section 32 and Verily, Ciitizen is working to build a global platform to help patients collect, organize, store and share their medical records digitally. The acquisition would enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, whic...

Read More
news image

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More
news image

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More
news image

Business Insights

AVIDIEN TECHNOLOGIES RECEIVES $4M INVESTMENT FROM BROADOAK CAPITAL PARTNERS

Avidien Technologies | February 02, 2022

Avidien announced a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. "The partnership with BroadOak is exciting and ushers in the next phase for Avidien by creating the opportunity to quickly scale up the business with investments in new products, sales, marketing, and manufacturing." ...

Read More
news image

Pharma Tech

INVITAE TO ACQUIRE CIITIZEN TO STRENGTHEN ITS PATIENT-CONSENTED HEALTH DATA PLATFORM TO IMPROVE PERSONAL OUTCOMES AND GLOBAL RESEARCH

Invitae | September 07, 2021

Invitae , a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z, Section 32 and Verily, Ciitizen is working to build a global platform to help patients collect, organize, store and share their medical records digitally. The acquisition would enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, whic...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us